微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.46% | 6.82% | 39.67% | 79/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.48% | -7.62% | 206.31% | 73/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.81% | 17.59% | -80.18% | 96/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 4.08% | 9.68% | 25.97% | 71/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 3.24% | -25.96% | 20.79% | 89/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.68% | -7.81% | 289.89% | 73/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.69% | 4.28% | -81.51% | 105/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 3.72% | 51.84% | -14.96% | 87/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 4.37% | 24.83% | 50.41% | 71/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.91% | 16.22% | 340.99% | 72/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.66% | 17.04% | -73.08% | 102/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 2.45% | 8.41% | -30.09% | 98/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 3.5% | 13.36% | 40.03% | 90/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 2.5% | 31.79% | 344.1% | 89/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.56% | 65.69% | -75.07% | 104/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 2.26% | 83.74% | -26.89% | 101/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.09% | 16.64% | 62.8% | 84/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 1.9% | 155.87% | 458.31% | 88/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.34% | -45.41% | -72.35% | 80/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 1.23% | -64.04% | -53.59% | 115/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.65% | -8.66% | 257.14% | 89/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 0.74% | -67.59% | 19.12% | 103/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.62% | 26.88% | -81.78% | 92/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.42% | 40.16% | 17.87% | 102/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 2.9% | 25.72% | 26.74% | 86/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 2.29% | 45.65% | 366.27% | 78/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.49% | 98.22% | -79.88% | 92/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.44% | 62.67% | 5.72% | 106/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.31% | -35.93% | 46.83% | 85/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.57% | -40.51% | 534.6% | 86/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.25% | 14.46% | -83.49% | 80/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 1.5% | -30.23% | -58.36% | 97/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 3.6% | 30.84% | 36.31% | 65/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.64% | 101.55% | 1121.12% | 61/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.22% | -20.56% | -89.93% | 73/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 2.15% | 416.18% | -21.9% | 85/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 2.75% | -29.05% | 109.98% | 59/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 1.31% | 91.63% | 381.31% | 63/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.27% | 135.68% | 140.06% | 65/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |